DK0980874T3 - Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer - Google Patents

Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer

Info

Publication number
DK0980874T3
DK0980874T3 DK99115386T DK99115386T DK0980874T3 DK 0980874 T3 DK0980874 T3 DK 0980874T3 DK 99115386 T DK99115386 T DK 99115386T DK 99115386 T DK99115386 T DK 99115386T DK 0980874 T3 DK0980874 T3 DK 0980874T3
Authority
DK
Denmark
Prior art keywords
improved method
properly connected
cysteine bridges
insulin precursors
recovering insulin
Prior art date
Application number
DK99115386T
Other languages
Danish (da)
English (en)
Inventor
Franz-Josef Dr Rubroeder
Reinhold Dr Keller
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0980874T3 publication Critical patent/DK0980874T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99115386T 1997-08-18 1998-08-11 Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer DK0980874T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
DK0980874T3 true DK0980874T3 (da) 2002-08-19

Family

ID=7839275

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98115048T DK0906918T3 (da) 1997-08-18 1998-08-11 Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer
DK99115386T DK0980874T3 (da) 1997-08-18 1998-08-11 Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK98115048T DK0906918T3 (da) 1997-08-18 1998-08-11 Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer

Country Status (20)

Country Link
US (3) US5986048A (cs)
EP (2) EP0906918B1 (cs)
JP (1) JP4291900B2 (cs)
KR (2) KR100537842B1 (cs)
CN (3) CN101186940B (cs)
AR (1) AR016821A1 (cs)
AT (2) ATE217012T1 (cs)
AU (1) AU744824B2 (cs)
BR (2) BRPI9816233B8 (cs)
CA (1) CA2245151C (cs)
CZ (1) CZ295679B6 (cs)
DE (3) DE19735711C2 (cs)
DK (2) DK0906918T3 (cs)
ES (2) ES2177178T3 (cs)
HU (2) HU228161B1 (cs)
ID (1) ID20717A (cs)
PL (1) PL191901B1 (cs)
PT (2) PT980874E (cs)
RU (2) RU2205836C2 (cs)
TR (1) TR199801587A2 (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
EP1242610A1 (en) * 1999-12-22 2002-09-25 Novo Nordisk A/S Method for extractive refolding of scrambledsingle-chain polypeptides
EP1303532A2 (en) * 2000-07-12 2003-04-23 Eli Lilly And Company Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
KR101067525B1 (ko) 2005-12-22 2011-09-27 제넨테크, 인크. 헤파린 결합 단백질의 재조합 생산
MY169472A (en) 2006-07-14 2019-04-12 Genentech Inc Refolding of recombinant proteins
CN101815944A (zh) * 2007-07-03 2010-08-25 安姆根有限公司 利用包含体干重的蛋白测量
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
MY152979A (en) 2008-01-09 2014-12-15 Sanofi Aventis Deutschland Novel insulin derivatives having an extremely delayed time-action profile
ES2522627T3 (es) * 2008-04-30 2014-11-17 Wockhardt Limited Procedimientos para el replegamiento de insulina
HRP20171894T1 (hr) 2008-10-17 2018-01-26 Sanofi-Aventis Deutschland Gmbh Kombinacija inzulina i agonista glp-1
PL2498801T3 (pl) 2009-11-13 2018-08-31 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę
WO2011058083A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
SI2611458T1 (sl) 2010-08-30 2017-01-31 Sanofi-Aventis Deutschland Gmbh Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
TWI708782B (zh) * 2013-02-26 2020-11-01 南韓商韓美藥品股份有限公司 新穎胰島素類似物及其用途
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
HRP20230470T1 (hr) 2014-12-12 2023-07-21 Sanofi-Aventis Deutschland Gmbh Formulacija fiksnog omjera inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
ATE350053T1 (de) * 1994-12-29 2007-01-15 Ferring Int Ct Sa Herstellung von humaninsulin
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
PL328108A1 (en) 1999-03-01
EP0906918A3 (de) 1999-08-11
PT906918E (pt) 2002-10-31
US6727346B2 (en) 2004-04-27
DK0906918T3 (da) 2002-09-09
HK1061870A1 (en) 2004-10-08
AR016821A1 (es) 2001-08-01
KR100537842B1 (ko) 2006-03-23
HU228203B1 (en) 2013-01-28
ES2177178T3 (es) 2002-12-01
CN101186940B (zh) 2012-02-08
BRPI9816233B8 (pt) 2021-05-25
TR199801587A3 (tr) 1999-03-22
EP0980874B1 (de) 2002-05-02
CZ295679B6 (cs) 2005-09-14
CA2245151A1 (en) 1999-02-18
DE59804121D1 (de) 2002-06-20
CN1483831B (zh) 2012-06-13
CN1132845C (zh) 2003-12-31
HK1119449A1 (en) 2009-03-06
HU0600287D0 (en) 2006-05-29
CN101186940A (zh) 2008-05-28
CN1209437A (zh) 1999-03-03
AU8076398A (en) 1999-02-25
US20020156234A1 (en) 2002-10-24
JP4291900B2 (ja) 2009-07-08
ATE217636T1 (de) 2002-06-15
CA2245151C (en) 2009-10-06
BRPI9816233B1 (pt) 2016-09-27
HU228161B1 (en) 2013-01-28
HU9801886D0 (en) 1998-10-28
US5986048A (en) 1999-11-16
AU744824B2 (en) 2002-03-07
KR20050067371A (ko) 2005-07-01
TR199801587A2 (xx) 1999-03-22
KR100574580B1 (ko) 2006-04-28
JPH11130798A (ja) 1999-05-18
ID20717A (id) 1999-02-18
EP0906918B1 (de) 2002-05-15
RU2302882C2 (ru) 2007-07-20
RU2205836C2 (ru) 2003-06-10
HUP9801886A2 (hu) 1999-01-28
ES2176870T3 (es) 2002-12-01
KR19990023651A (ko) 1999-03-25
CN1483831A (zh) 2004-03-24
EP0906918A2 (de) 1999-04-07
DE19735711A1 (de) 1999-02-25
EP0980874A1 (de) 2000-02-23
ATE217012T1 (de) 2002-05-15
DE19735711C2 (de) 2001-04-26
BR9803755A (pt) 2000-03-28
DE59803985D1 (de) 2002-06-06
CZ259898A3 (cs) 1999-03-17
PT980874E (pt) 2002-10-31
US6380355B1 (en) 2002-04-30
PL191901B1 (pl) 2006-07-31
HK1018464A1 (en) 1999-12-24
HUP9801886A3 (en) 1999-06-28

Similar Documents

Publication Publication Date Title
DK0980874T3 (da) Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer
DK0914189T3 (da) Fremgangsmåde til genvinding af procesvæsker
DK1015388T3 (da) Fremgangsmåde til inhibering af biogen sulfiddannelse
FI950699L (fi) Menetelmä insuliinin saamiseksi, jossa on oikein sitoutuneet kystiinisillat
DE59909597D1 (de) Verfahren zur kontrolle der insulinmedikation
NO20003050D0 (no) Metode for Õ administrere monomere insulinanaloger
NO20010982D0 (no) FremgangsmÕte for Õ administrere insulinotropiske peptider
DE69735527D1 (de) Digitales Verfahren zur adaptiven Taktrückgewinnung
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
DK0998473T3 (da) Krystalmodifikation af et N-phenyl-2-pyrimidinaminderivat, fremgangsmåder til fremstilling deraf samt dets anvendelse
DK0885968T3 (da) Fremgangsmåde til fremstilling af vanillin
FI970388A0 (fi) Menetelmä kuvasekvenssien kontrastin parantamiseksi
DK199901814A (da) Fremgangsmåde til fortætning af en naturgasstrøm, der indeholder mindst én frysbar komponent
DK1176195T3 (da) Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1230247T3 (da) Fremgangsmåde til stabilisering af siloxanforbindelser
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
DK0917879T3 (da) Forbedret fremgangsmåde til stabilisering af proteiner
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0946531T3 (da) Fremgangsmåde til fremstilling af thiazol-derivater
DK1100346T3 (da) Fremgangsmåde til fremstilling af restruktureret kød med en lagdelt struktur
DE69835190D1 (de) Schaltung zur Taktrückgewinnung
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK1300160T3 (da) Fremgangsmåde til stabilisering af en sammensætning
DK1062358T3 (da) Ny fremgangsmåde til fremstilling af fexofenadin